Arimoclomol international efficacy trial kick-off meeting in LA

Profesor Michael Hanna in Los Angeles for an Investigators meeting, kicking off the international efficacy trial based on MRC centre & Kansas preclinical & phase 2 data.

With their partner Orphazyme, this ~€14m trial will establish whether heat shock protein upregulation improves the disabling muscle disease inclusion body myositis. pic.twitter.com/KjrleqxGF1

---